Intrinsic Value
Keros Therapeutics, Inc. (KROS)
$47.83
-0.81 (-1.67%)
| Enterprise Value | - |
|---|---|
| Net Debt | -265.78 |
| Equity Value | - |
| Shares Outstanding | 25.24 |
| Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt